Crestline Management’s Qiagen QGEN Stock Holding History

Crestline Management’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,886	Closed	-$407K	–	501
2024 Q4	$407K	Buy	+8,886	New	+$398K	0.01%	574

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Crestline Management's QGEN Position: Q1 2025 in Review

Crestline Management sold out of Qiagen (QGEN) in Q1 2025, closing a stake of 8,886 shares — an estimated $407K sold.

Crestline Management first reported a position in QGEN in Q4 2024 and held it in 1 quarter. The position peaked at $407K in Q4 2024. 298 funds tracked by Wall St. Rank hold QGEN as of Q1 2025.

Crestline Management reported no remaining Qiagen position as of Q1 2025 after selling out during the quarter.
Crestline Management sold 8,886 Qiagen shares in Q1 2025, an estimated $407K.
Crestline Management first reported a position in Qiagen in Q4 2024 and held it in 1 quarter.
Crestline Management's Qiagen position peaked at $407K in Q4 2024.
298 funds tracked by Wall St. Rank held Qiagen as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.